Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study (Q33389870)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study |
scientific article |
Statements
1 reference
Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study (English)
1 reference
John R Zalcberg
1 reference
Niall C Tebbutt
1 reference
Kate Wilson
1 reference
Val J Gebski
1 reference
Michelle M Cummins
1 reference
Diana Zannino
1 reference
Guy A van Hazel
1 reference
Adam Broad
1 reference
Vinod Ganju
1 reference
Stephen P Ackland
1 reference
Garry Forgeson
1 reference
Mark P Saunders
1 reference
Martin R Stockler
1 reference
Yujo Chua
1 reference
R John Simes
1 reference
1 reference
Identifiers
1 reference